Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life von Droege, Katharina M., Muether, Philipp S., Hermann, Manuel M., Caramoy, Albert, Viebahn, Ulrike, Kirchhof, Bernd, Fauser, Sascha

Volltext

Retinal layers measurements in healthy eyes and in eyes receiving silicone oil‐based endotamponade von Caramoy, Albert, Droege, Katharina M., Kirchhof, Bernd, Fauser, Sascha

Volltext

Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration — monthly injections versus pro re nata von Droege, Katharina M., Caramoy, Albert, Kersten, Andreas, Luberichs-Fauser, Janina, Zilkens, Katharina, Müller, Dirk, Kirchhof, Bernd, Fauser, Sascha

Volltext

The Genome Sequencer FLX™ System—Longer reads, more applications, straight forward bioinformatics and more complete data sets von Droege, Marcus, Hill, Brendon

Volltext

EE591 Economic Modeling Considerations for Rare Neurodegenerative Diseases of Infancy and Early Childhood von Paret, K, Ronquest, N, Droege, M

Volltext

Pharmacokinetics and Pharmacodynamics of Extended‐Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open‐Label Study

Volltext

Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab von Muether, Philipp S, Droege, Katharina M, Fauser, Sascha

Volltext

Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment von Lenfers, B. H. M., Loeffler, T. M., Droege, C. M., Hausamen, T. U.

Volltext

PND24 Burden of Illness of Spinal Muscular Atrophy: An Update von Droege, M., Dabbous, O., Arjunji, R., Patel, A., Gauthier-Loiselle, M., Cloutier, M., Sproule, D.M.

Volltext

SMA - CLINICAL: P.78 Burden of illness of spinal muscular atrophy type 1 (SMA1): an update von Droege, M., Dabbous, O., Arjunji, R., Gauthier-Loiselle, M., Cloutier, M., Sproule, D.

Volltext

SMA - CLINICAL von Droege, M., Dabbous, O., Arjunji, R., Gauthier-Loiselle, M., Cloutier, M., Sproule, D.

Volltext

Burden of illness of spinal muscular atrophy type 1 (SMA1) von Droege, M., Dabbous, O., Arjunji, R., Seda, J., Gauthier-Loiselle, M., Cloutier, M., Sproule, D.M.

Volltext

SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES von Dabbous, O., Seda, J., Droege, M., Sproule, D.

Volltext

SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P.95Economic burden of infant-onset (type 1) spinal muscular atrophy: a retrospective claims database analysis von Dabbous, O., Seda, J., Droege, M., Sproule, D.

Volltext

The value of onasemnogene abeparvovec (AVXS-101) gene-replacement therapy for spinal muscular atrophy type 1 von Dabbous, O., Sproule, D.M., Feltner, D.E., Droege, M., Khan, F., Arjunji, R.

Volltext

P.210Burden of illness of spinal muscular atrophy type 1 (SMA1) von Droege, M., Dabbous, O., Arjunji, R., Seda, J., Gauthier-Loiselle, M., Cloutier, M., Sproule, D.

Volltext

Illuminating the Evolutionary History of Chlamydiae von Horn, Matthias, Collingro, Astrid, Schmitz-Esser, Stephan, Beier, Cora L., Purkhold, Ulrike, Fartmann, Berthold, Brandt, Petra, Nyakatura, Gerald J., Droege, Marcus, Frishman, Dmitrij, Rattei, Thomas, Mewes, Hans-Werner, Wagner, Michael

Volltext

SMA – THERAPY: P.262 Value of onasemnogene abeparvovec in spinal muscular atrophy type 1: improvements in motor function, ventilation-free survival, and hospitalizations von Dabbous, O., Reyna, S., Feltner, D., Ogrinc, F., Menier, M., Ouyang, H., Droege, M., Bischof, M., LaMarca, N., Arunji, R.

Volltext

SMA – THERAPY von Dabbous, O., Reyna, S., Feltner, D., Ogrinc, F., Menier, M., Ouyang, H., Droege, M., Bischof, M., LaMarca, N., Arunji, R.

Volltext

P.358The value of AVXS-101 gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): improved survival, pulmonary and nutritional support, and motor function with d... von Dabbous, O., Sproule, D., Feltner, D., Droege, M., Khan, F., Arjunji, R.

Volltext